These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 30764633)

  • 1. Effective Immunotherapy of Glioblastoma in an Adolescent with Constitutional Mismatch Repair-Deficiency Syndrome.
    Pavelka Z; Zitterbart K; Nosková H; Bajčiová V; Slabý O; Štěrba J
    Klin Onkol; 2019; 32(1):70-74. PubMed ID: 30764633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency.
    Chmara M; Wernstedt A; Wasag B; Peeters H; Renard M; Beert E; Brems H; Giner T; Bieber I; Hamm H; Sciot R; Wimmer K; Legius E
    Genes Chromosomes Cancer; 2013 Jul; 52(7):656-64. PubMed ID: 23629955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome.
    Westdorp H; Kolders S; Hoogerbrugge N; de Vries IJM; Jongmans MCJ; Schreibelt G
    Cancer Lett; 2017 Sep; 403():159-164. PubMed ID: 28645564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutional mismatch repair-deficiency and whole-exome sequencing as the means of the rapid detection of the causative MSH6 defect.
    Hoell JI; Gombert M; Ginzel S; Loth S; Landgraf P; Käfer V; Streiter M; Prokop A; Weiss M; Thiele R; Borkhardt A
    Klin Padiatr; 2014 Nov; 226(6-7):357-61. PubMed ID: 25431869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.
    Bouffet E; Larouche V; Campbell BB; Merico D; de Borja R; Aronson M; Durno C; Krueger J; Cabric V; Ramaswamy V; Zhukova N; Mason G; Farah R; Afzal S; Yalon M; Rechavi G; Magimairajan V; Walsh MF; Constantini S; Dvir R; Elhasid R; Reddy A; Osborn M; Sullivan M; Hansford J; Dodgshun A; Klauber-Demore N; Peterson L; Patel S; Lindhorst S; Atkinson J; Cohen Z; Laframboise R; Dirks P; Taylor M; Malkin D; Albrecht S; Dudley RW; Jabado N; Hawkins CE; Shlien A; Tabori U
    J Clin Oncol; 2016 Jul; 34(19):2206-11. PubMed ID: 27001570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lynch syndrome-associated ultra-hypermutated pediatric glioblastoma mimicking a constitutional mismatch repair deficiency syndrome.
    Yang C; Austin F; Richard H; Idowu M; Williamson V; Sabato F; Ferreira-Gonzalez A; Turner SA
    Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31604779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Causes of Rare Pediatric Ovarian Tumors.
    Plevová P; Geržová H
    Klin Onkol; 2019; 32(Supplementum2):79-91. PubMed ID: 31409083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline Biallelic Mismatch Repair Deficiency in Childhood Glioblastoma and Implications for Clinical Management.
    Mishra AK; Achari RB; Zameer L; Achari G; Gehani A; Roy P; Sudhaman S; Bianchi V; Edwards M; Sen S; Sukumaran RK; Bhattacharyya A; Tabori U; Das A
    Neurol India; 2022; 70(2):772-774. PubMed ID: 35532657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and therapeutic challenges of glioblastoma as an initial malignancy of constitutional mismatch repair deficiency (CMMRD): two case reports and a literature review.
    Onishi S; Yamasaki F; Kuraoka K; Taguchi A; Takayasu T; Akagi K; Hinoi T
    BMC Med Genomics; 2023 Jan; 16(1):6. PubMed ID: 36647049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Update on Inherited Colon Cancer and Gastrointestinal Polyposis.
    Plevová P
    Klin Onkol; 2019; 32(Supplementum2):97-108. PubMed ID: 31409085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal Polyposes and Lynch Syndrome - a Pathologists Perspective.
    Pokorová Š; Fabian P
    Klin Onkol; 2019; 32(Supplementum2):92-96. PubMed ID: 31409084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapy of Colorectal and Anal Carcinoma].
    Tomášek J; Kiss I
    Klin Onkol; 2017; 30(Supplementum3):62-65. PubMed ID: 29239195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel PMS2 alteration c.505C>G (R169G) in trans with a PMS2 pathogenic mutation in a patient with constitutional mismatch repair deficiency.
    Mork ME; Borras E; Taggart MW; Cuddy A; Bannon SA; You YN; Lynch PM; Ramirez PT; Rodriguez-Bigas MA; Vilar E
    Fam Cancer; 2016 Oct; 15(4):587-91. PubMed ID: 27017610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Mutation Analysis of PMS2 in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency Syndrome.
    van der Klift HM; Mensenkamp AR; Drost M; Bik EC; Vos YJ; Gille HJ; Redeker BE; Tiersma Y; Zonneveld JB; García EG; Letteboer TG; Olderode-Berends MJ; van Hest LP; van Os TA; Verhoef S; Wagner A; van Asperen CJ; Ten Broeke SW; Hes FJ; de Wind N; Nielsen M; Devilee P; Ligtenberg MJ; Wijnen JT; Tops CM
    Hum Mutat; 2016 Nov; 37(11):1162-1179. PubMed ID: 27435373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort.
    Lavoine N; Colas C; Muleris M; Bodo S; Duval A; Entz-Werle N; Coulet F; Cabaret O; Andreiuolo F; Charpy C; Sebille G; Wang Q; Lejeune S; Buisine MP; Leroux D; Couillault G; Leverger G; Fricker JP; Guimbaud R; Mathieu-Dramard M; Jedraszak G; Cohen-Hagenauer O; Guerrini-Rousseau L; Bourdeaut F; Grill J; Caron O; Baert-Dusermont S; Tinat J; Bougeard G; Frébourg T; Brugières L
    J Med Genet; 2015 Nov; 52(11):770-8. PubMed ID: 26318770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutional mismatch repair deficiency presenting in childhood as three simultaneous malignancies.
    Walter AW; Ennis S; Best H; Vaughn CP; Swensen JJ; Openshaw A; Gripp KW
    Pediatr Blood Cancer; 2013 Nov; 60(11):E135-6. PubMed ID: 23729388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Tumor Size and p16 Status on Treatment Outcomes - Achievement of Complete Remission in Prospectively Followed Patients with Oropharyngeal Tumors.
    Slavik M; Kazda T; Selingerová I; Šána J; Ahmad P; Gurín D; Hermanová M; Novotný T; Červená R; Dymáčková R; Burkoň P; Slabý O; Šlampa P
    Klin Onkol; 2019; 32(1):58-65. PubMed ID: 30764631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging Findings in Children with Constitutional Mismatch Repair Deficiency Syndrome.
    Kerpel A; Yalon M; Soudack M; Chiang J; Gajjar A; Nichols KE; Patay Z; Shrot S; Hoffmann C
    AJNR Am J Neuroradiol; 2020 May; 41(5):904-910. PubMed ID: 32354708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary brain tumor with a homozygous germline mutation in PMS2: pedigree analysis and prenatal screening in a family with constitutional mismatch repair deficiency (CMMRD) syndrome.
    Baig SM; Fatima A; Tariq M; Khan TN; Ali Z; Faheem M; Mahmood H; Killela P; Waitkus M; He Y; Zhao F; Wang S; Jiao Y; Yan H
    Fam Cancer; 2019 Apr; 18(2):261-265. PubMed ID: 30478739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ongoing issues with the management of children with Constitutional Mismatch Repair Deficiency syndrome.
    Farah RA; Maalouf F; Chahine NA; Farhat H; Campbell B; Zhukova N; Durno C; Aronson M; Hawkins C; Bouffet E; Tabori U
    Eur J Med Genet; 2019 Aug; 62(8):103706. PubMed ID: 31233827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.